1. PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
   Qianhui Dou et al, 2023, Cellular and Molecular Gastroenterology and Hepatology CrossRef
2. Independent prognostic value of HIF‑1α expression in radiofrequency ablation of lung cancer
   Jun Wan et al, 2019, Oncology Letters CrossRef
3. Comparison between radiofrequency ablation and sublobar resections for the therapy of stage I non-small cell lung cancer: a meta-analysis
   Shuang Chen et al, 2020, PeerJ CrossRef
4. Mechanisms of Fritillariae Thunbergii Flos in lung cancer treatment from a systems pharmacology perspective
   Mingchao Cui et al, 2021, Journal of Ethnopharmacology CrossRef
5. Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma
   Weining Wu et al, 2017, Scientific Reports CrossRef
6. Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
   Chunying Xiao et al, 2023, Frontiers in Pharmacology CrossRef
7. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways
   Jun Wan et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
8. Impact of Interventional Oncology Therapies on Tumor Microenvironment and Strategies to Enhance Their Efficacy
   Stacy K. Y. Fan et al, 2018, American Journal of Roentgenology CrossRef
9. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma
   Rui-Xue Tang et al, 2017, Oncotarget CrossRef
10. HSP70 via HIF-1 α SUMOylation inhibits ferroptosis inducing lung cancer recurrence after insufficient radiofrequency ablation
    Bin Peng et al, 2023, PLOS ONE CrossRef
11. Small cell lung cancer treated by radiofrequency ablation
    Guo-qiang Song et al, 2017, Medicine CrossRef